CLASS II Device recall · Reported 23 May 2018 · FDA Enforcement Report

Tosoh ST Aia-pack HbA1c, HbA1c Reagent, Pt recalled by Tosoh Bioscience

Tosoh Bioscience is recalling Tosoh ST Aia-pack HbA1c, HbA1c Reagent, Pt, distributed nationwide in the US. The recall was initiated on 5 Mar 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots.
Quantity recalled6049

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1809-2018
FDA event ID
79708
Recalling firm
Tosoh Bioscience, Grove City, OH
Classification
Class II
Status
Terminated
Recall initiated
5 Mar 2018
FDA classified
14 May 2018
Reported
23 May 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

5 Mar 2018Recall initiated by company
14 May 2018Classified by FDA+70 days
23 May 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Tosoh ST AIA-PACK HbA1c, HbA1c Reagent, Pt. No. 025218 The device is designed for In Vitro Diagnostic Use Only for the quantitative measurement for percent concentration of Hemoglobin A1c (HbA1c) in EDTA whole blood on Tosoh AIA System Analyzer. HbA1c measurement is used in the management and treatment of diabetes.

Where it was distributed

USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

Nationwide AlabamaArkansasArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIowaIdahoIllinoisKansasKentuckyLouisianaMassachusettsMarylandMichiganMissouriNorth CarolinaNebraska

Questions about this recall

Is Tosoh ST Aia-pack HbA1c, HbA1c Reagent, Pt recalled?

Yes. Tosoh Bioscience recalled Tosoh ST Aia-pack HbA1c, HbA1c Reagent, Pt on 5 Mar 2018. The recall is Class II and its status is Terminated. Recall number Z-1809-2018.

Why was it recalled?

The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Which lots are affected?

All lots.

Where was it sold?

USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tosoh Bioscience

All 74

Other Test Kits & Diagnostics recalls

All 2,656